The Fiji TimesU.S. FDA approves Mirati's lung cancer drug fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.
The U.S. Food and Drug Administration
approved Mirati Therapeutics Inc s lung cancer drug
adagrasib, the company said on Monday, sending its shares up
more than 8% in extended trading. . | December 12, 2022
By Deena Beasley (Reuters) - The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a 53% increase from 20.
The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a 53% increase from 2017, according to a new report from U.S.
By Deena Beasley (Reuters) - The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a 53% increase from 20.